GlassScriptPhysician profile
Huey G Mcdaniel
NPI 1619916277
$8,217.20
in general payments reported to CMS, 2019-2025
37 companies · $40.52 in 2025
The $40.52 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,261 · 2020: $1,640 · 2021: $2,121 · 2022: $2,098 · 2023: $42.50 · 2024: $13.98 · 2025: $40.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,187.25 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $917.86 | 2019-2022 | |
| Lilly USA, LLC | $893.72 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $572.27 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $503.54 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $413.19 | 2019-2022 | |
| Amgen INC. | $339.94 | 2019-2022 | |
| Antares Pharma, INC. | $334.73 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $268.61 | 2020-2022 | |
| Dexcom, INC. | $249.02 | 2019-2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $247.51 | 2019-2020 | |
| Becton, Dickinson and Company | $245.82 | 2019-2022 | |
| Corcept Therapeutics | $237.78 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $235.70 | 2019-2020 | |
| Abbott Laboratories | $213.96 | 2020-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $180.22 | 2019-2021 | |
| Clarus Therapeutics INC. | $157.60 | 2021 | |
| Boston Scientific Corporation | $119.22 | 2021 | |
| Radius Health, INC. | $117.46 | 2019-2021 | |
| Insulet Corporation | $116.66 | 2019-2022 | |
| Medtronic, INC. | $87.22 | 2021-2022 | |
| Mannkind Corporation | $86.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $79.05 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.62 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.91 | 2021-2022 | |
| Eisai INC. | $44.01 | 2019-2021 | |
| Tactile Systems Technology INC | $40.52 | 2025 | Flexitouch Plus, Nimbl |
| Ultragenyx Pharmaceutical INC. | $40.19 | 2020-2022 | |
| Shire North American Group INC | $33.31 | 2019 | |
| Esperion Therapeutics, INC. | $24.55 | 2021 | |
| Medtronic Minimed, INC. | $22.55 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $19.02 | 2022 | |
| Opko Pharmaceuticals, LLC | $15.88 | 2021 | |
| Rochester Medical Corporation | $13.97 | 2021 | |
| Currax Pharmaceuticals LLC | $13.26 | 2022 | |
| Pfizer INC. | $13.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huey Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.